Samarind provides Regulatory Information Management (RIM) solutions to the life sciences sector, that help pharmaceutical, biotech and medical device companies achieve and maintain compliance for their products while improving the quality and consistency of their regulatory information.
Ennov is a leading provider of regulated content and data management software for the Life Sciences industry. The acquisition will further strengthen Ennov’s position in the Regulatory Information Management (RIM) software market, especially in the Medical Device sector, where Samarind is well positioned.
Greg Barker, director of Strategic Corporate Finance acted as lead deal advisor to Instem plc and was responsible for introducing Ennov S.A.S. as a potential acquirer, leading deal negotiations and transaction management through to completion.